 Antiinflammatory antiarthritic properties substituted quinoline carboxylic acid CL CL substituted quinoline carboxylic acid daily oral dose mg/kg inflammation joint destruction radiological criteria adjuvant arthritis weekly oral regimen joint destruction agent dose mg/kg Inflammation delayed type hypersensitivity reaction dogs daily dose mg/kg weekly dose mg/kg efficacious doses CL effects cyclooxygenase lipoxygenase activities effect carrageenin paw edema acute tests compound ulcerogenic observations antiinflammatory effects CL distinct nonsteroidal antiinflammatory agents Mechanistic studies CL regulates cell function mechanism part antiinflammatory antiarthritic properties animal models inflammation joint destruction